Wakamoto Pharmaceutical Co.,Ltd. Stock

Equities

4512

JP3991200001

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-05-13 EDT 5-day change 1st Jan Change
236 JPY +2.16% Intraday chart for Wakamoto Pharmaceutical Co.,Ltd. +3.06% +10.80%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2011 9.67B 61.88M 84.56M Sales 2012 9.43B 60.36M 82.48M Capitalization 8.59B 55.01M 75.16M
Net income 2011 -425M -2.72M -3.72M Net income 2012 -222M -1.42M -1.94M EV / Sales 2011 0.9 x
Net cash position 2011 156M 998K 1.36M Net cash position 2012 212M 1.36M 1.85M EV / Sales 2012 0.89 x
P/E ratio 2011
-20.8 x
P/E ratio 2012
-38.7 x
Employees 403
Yield 2011 *
-
Yield 2012
-
Free-Float 63.42%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.16%
1 week+3.06%
Current month+2.61%
1 month+1.72%
3 months+12.92%
6 months+17.41%
Current year+10.80%
More quotes
1 week
229.00
Extreme 229
241.00
1 month
221.00
Extreme 221
243.00
Current year
197.00
Extreme 197
252.00
1 year
189.00
Extreme 189
261.00
3 years
189.00
Extreme 189
410.00
5 years
188.00
Extreme 188
754.00
10 years
188.00
Extreme 188
754.00
More quotes
Managers TitleAgeSince
President 65 10-04-30
Director/Board Member 58 88-03-31
Director/Board Member 67 79-03-31
Members of the board TitleAgeSince
Director/Board Member 70 16-05-31
Director/Board Member 67 79-03-31
President 65 10-04-30
More insiders
Date Price Change Volume
24-05-13 236 +2.16% 136 800
24-05-10 231 0.00% 28,700
24-05-09 231 -0.86% 40,400
24-05-08 233 -0.43% 70,000

Delayed Quote Japan Exchange, May 13, 2024 at 02:00 am

More quotes
WAKAMOTO PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of ethical drugs such as gastrointestinal drugs and non-prescription drugs. The Company operates through four business segments. The Pharmaceuticals segment is involved in the manufacture and sale of innovator drugs, generic drugs and optiaid series supplements mainly in the ophthalmic field, as well as the commission of production and the sale of diagnostic drugs and raw materials in Japan. The Healthcare segment sales its core product Kawakami Wakamoto, the Avantbise series of medicated toothpastes that promote bad breath prevention based on evidence and Avantbise Oral Tablet mainly in the mail order business. The International segment is involved in the business related to the export of products and raw materials mainly in Asia and Europe, as well as the new license in and out business. The Real Estate Leasing segment is involved in the rental business of Coredo Muromachi.
Calendar
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW